Dr. Uma Ramaswami, MD
Claim this profileRoyal Free London NHS Foundation Trust
Studies Niemann-Pick Disease
Studies Primary Progressive Aphasia
2 reported clinical trials
3 drugs studied
Area of expertise
1Niemann-Pick Disease
NPC2 positive
NPC1 positive
2Primary Progressive Aphasia
NPC2 positive
NPC1 positive
Clinical Trials Uma Ramaswami, MD is currently running
N-Acetyl-L-Leucine
for Niemann-Pick Disease Type C
A pivotal, randomized, double-blind, placebo controlled, multi-center therapeutic study for patients age 4 and older with a confirmed diagnosis of Niemann Pick disease type C (NPC). The objective of this study is to evaluate the safety, tolerability and efficacy of N-acetyl-L-leucine (IB1001) compared to standard of care. Following this randomized, double-blind, placebo-controlled "Parent Study", an extension phase is conducted for (1) patients who completed the "Parent Study" and (2) patients who are enrolled directly into the Extension Phase. Currently, the Extension Phase provides patients with 3 years of open-label treatment.
Recruiting1 award Phase 310 criteria
Tividenofusp Alfa
for Hunter Syndrome
This trial is testing a new treatment called tividenofusp alfa for patients with a rare genetic disorder called MPS II. The treatment aims to replace missing enzymes to help break down harmful substances in the brain and body.
Recruiting1 award Phase 2 & 33 criteria
More about Uma Ramaswami, MD
Clinical Trial Related2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Uma Ramaswami, MD has experience with
- N-Acetyl-L-Leucine
- DNL310
- Idursulfase
Breakdown of trials Uma Ramaswami, MD has run
Niemann-Pick Disease
Primary Progressive Aphasia
Frontotemporal Dementia
Pick's Disease
Hunter Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Uma Ramaswami, MD specialize in?
Uma Ramaswami, MD focuses on Niemann-Pick Disease and Primary Progressive Aphasia. In particular, much of their work with Niemann-Pick Disease has involved NPC2 positive patients, or patients who are NPC1 positive.
Is Uma Ramaswami, MD currently recruiting for clinical trials?
Yes, Uma Ramaswami, MD is currently recruiting for 2 clinical trials in the USA. If you're interested in participating, you should apply.
Are there any treatments that Uma Ramaswami, MD has studied deeply?
Yes, Uma Ramaswami, MD has studied treatments such as N-Acetyl-L-Leucine, DNL310, Idursulfase.
What is the best way to schedule an appointment with Uma Ramaswami, MD?
Apply for one of the trials that Uma Ramaswami, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.